BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 89 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $658,307 | +0.6% | 45,684 | +14.6% | 0.01% | 0.0% |
Q2 2023 | $654,357 | +18.9% | 39,851 | +21.0% | 0.01% | +11.1% |
Q1 2023 | $550,194 | +31.7% | 32,926 | +21.6% | 0.01% | +28.6% |
Q4 2022 | $417,657 | -5.7% | 27,068 | -8.7% | 0.01% | -12.5% |
Q3 2022 | $443,000 | +23.4% | 29,642 | +35.6% | 0.01% | +14.3% |
Q2 2022 | $359,000 | +12.5% | 21,867 | +37.4% | 0.01% | +40.0% |
Q1 2022 | $319,000 | +25.1% | 15,910 | +58.5% | 0.01% | +25.0% |
Q4 2021 | $255,000 | +68.9% | 10,038 | +79.8% | 0.00% | +33.3% |
Q3 2021 | $151,000 | +14.4% | 5,584 | +22.0% | 0.00% | +50.0% |
Q2 2021 | $132,000 | -100.0% | 4,578 | -96.7% | 0.00% | -93.8% |
Q1 2021 | $3,622,526,000 | +1078032.7% | 137,738 | +878.9% | 0.03% | +300.0% |
Q3 2020 | $336,000 | – | 14,070 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
Matisse Capital | 51,296 | $739,175 | 0.52% |
Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |